Rate and Determinants of Residual Viremia in Multidrug-Experienced Patients Successfully Treated with Raltegravir-Based RegimensSilvia Baroncelli, Marco Floridia, Maria Franca Pirillo et al.|AIDS Research and Human Retroviruses|2014Cited by 10
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factorsRaffaella Bucciardini, Marco Floridia, Giustino Parruti et al.|International Journal of STD & AIDS|2012Cited by 10